Prof Dr Uwe Pleyer of Charité Universitätsmedizin Berlin moderated two sessions at the International Ocular Inflammation Society (IOIS) meeting 2019 in Kaohsiung, Taiwan: “Immunology of Cornea/Sclera– update in diagnosis and therapy” and the “Minimum Clinical Datasets in Uveitis – What is this and do we need it?” The meeting took place on November 13- 16, 2019. 
In addition, Uwe (pictured left, third from the left) presented a talk entitled: “The role of immune-modulatory stromal cell therapy in prevention of corneal graft rejection” wherein VISICORT was presented on Saturday, November 16th. Download the IOIS meeting programme 2019 here.
The International Ocular Inflammation Society (IOIS) is an independent scientific society, interested in the study of ocular inflammatory diseases. It aims to create a comprehensive platform for ocular inflammations and infections.
VISICORT has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 602470. The material presented and views expressed here are the responsibility of the author(s) only. The EU Commission takes no responsibility for any use made of the information set out.